The Baker Heart and Diabetes Institute, commonly known as the Baker Institute, is an Australian independent medical research institute headquartered in Melbourne, Victoria. Established in 1926, the institute is one of Australia's oldest medical research organisations with a historical focus on cardiovascular disease.

During the past decade, Baker Heart and Diabetes Institute conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 5 clinical trials were completed, i.e. on average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baker Heart and Diabetes Institute" #1 sponsor was "Baker Heart and Diabetes Institute" with 13 trials, followed by "Baker Heart Research Institute" with 5 trials sponsored, "Bayside Health" with 3 trials sponsored, "Chelsea Therapeutics" with 2 trials sponsored and "ResMed" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baker Heart and Diabetes Institute" #1 collaborator was "National Health and Medical Research Council, Australia" with 4 trials as a collaborator, "Monash Medical Centre" with 3 trials as a collaborator, "The Alfred" with 3 trials as a collaborator, "Baker Heart and Diabetes Institute" with 2 trials as a collaborator and "Ballarat Health Services" with 2 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Baker Heart and Diabetes Institute" are "Hypertension" (4 trials), "Obesity" (3 trials), "Type 2 Diabetes" (3 trials), "Coronary Artery Disease" (2 trials) and "Diabetes Mellitus, Type 2" (2 trials). Many other conditions were trialed in "Baker Heart and Diabetes Institute" in a lesser frequency.

Most popular intervention types in "Baker Heart and Diabetes Institute" are "Drug" (19 trials), "Other" (6 trials), "Behavioral" (3 trials), "Device" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Renal Denervation" (3 trials), "Droxidopa" (2 trials), "Moxonidine" (2 trials) and "Usual care" (2 trials). Other intervention names were less common.

The vast majority of trials in "Baker Heart and Diabetes Institute" are 27 trials for "All" genders, 4 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Baker Heart and Diabetes Institute". undefined are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Baker Heart and Diabetes Institute, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Baker Heart and Diabetes Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 13 trials that are defined as “Not Applicable".

Baker Heart and Diabetes Institute has several departments that took part in Clinical trials: "Alfred & Baker Medical Unit" - 2 trials